Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | BlackRock Inc. BLK | 671,445 8.800% | 104,229 (+18.38%) | Filing History |
| 2024-01-22 1:50 pm Sale | 2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 136,918 1.790% | -10,573 (-7.17%) | Filing History |
| 2023-07-10 2:26 pm Sale | 2023-06-30 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 147,491 1.940% | -404,978 (-73.30%) | Filing History |
| 2023-02-14 4:21 pm Purchase | 2022-12-31 | 13G | Epizyme, Inc. EPZM | Palo Alto Investors LP | 5,655,676 5.000% | 5,655,676 (New Position) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Commodore Capital LP | 129,041 1.700% | -138,363 (-51.74%) | Filing History |
| 2023-02-14 3:41 pm Sale | 2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Chione Ltd. | 293,333 3.900% | -40,000 (-12.00%) | Filing History |
| 2023-02-14 3:31 pm Purchase | 2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Avidity Partners Management LP | 758,738 9.900% | 1,950 (+0.26%) | Filing History |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Rubric Capital Management LP | 552,975 7.330% | 552,975 (New Position) | Filing History |
| 2023-02-02 12:38 pm Purchase | 2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 552,469 7.320% | 184,890 (+50.30%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | BlackRock Inc. BLK | 567,216 10.500% | 0 (Unchanged) | Filing History |
| 2023-01-20 5:17 pm Sale | 2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | BlackRock Inc. BLK | 567,216 10.500% | -27,331 (-4.60%) | Filing History |
| 2022-12-08 10:22 am Purchase | 2022-12-05 | 13G | Karyopharm Therapeutics Inc. KPTI | Avidity Partners Management LP | 756,788 9.900% | 756,788 (New Position) | Filing History |
| 2022-05-09 4:30 pm Purchase | 2022-04-27 | 13G | Karyopharm Therapeutics Inc. KPTI | Commodore Capital LP | 267,403 5.100% | 267,403 (New Position) | Filing History |
| 2022-02-14 5:09 pm Purchase | 2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Palo Alto Investors LP | 364,697 7.240% | 13,520 (+3.85%) | Filing History |
| 2022-02-11 4:01 pm Sale | 2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Kauffman Michael | 271,888 5.200% | -10,209 (-3.62%) | Filing History |
| 2022-02-11 2:54 pm Sale | 2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Chione Ltd. | 333,333 6.600% | -33,333 (-9.09%) | Filing History |
| 2022-02-11 08:38 am Sale | 2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 367,579 7.300% | -167,088 (-31.25%) | Filing History |
| 2022-01-27 5:13 pm Unchanged | 2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | BlackRock Inc. BLK | 594,547 11.800% | 0 (Unchanged) | Filing History |
| 2022-01-26 09:16 am Purchase | 2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | BlackRock Inc. BLK | 594,547 11.800% | 96,207 (+19.31%) | Filing History |
| 2021-10-12 12:23 pm Purchase | 2021-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI | STATE STREET CORP STT | 534,667 10.620% | 178,676 (+50.19%) | Filing History |